FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: If approved, this new vaccine could affect public health initiatives and vaccine availability across Ohio, potentially influencing local healthcare providers' strategies for flu season.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.